Search

Viking Therapeutics Inc

Suletud

SektorTervishoid

31.38 -1.69

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

31.78

Max

32.08

Põhinäitajad

By Trading Economics

Sissetulek

30M

-128M

Aktsiakasum

-1.1

Töötajad

65

EBITDA

30M

-128M

Dividendid

By Acuity

Järgmine tulemuste avaldamine

21. okt 2026

Turustatistika

By TradingEconomics

Turukapital

19M

4.1B

Eelmine avamishind

33.07

Eelmine sulgemishind

31.38

Uudiste sentiment

By Acuity

50%

50%

126 / 339 Pingereas Healthcare

Viking Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

11. sept 2026, 23:06 UTC

Viking Therapeutics Inc. shares are higher in after-market trading, despite routine fluctuations, and remain below their 20-day moving average.

10. sept 2026, 20:07 UTC

Correlated Moves
Social Media

Viking Therapeutics Inc shares are lower, influenced by a declining broader market and volatility in the biotech sector amid rising Treasury yields and inflation concerns.

9. sept 2026, 23:11 UTC

Viking Therapeutics Inc shares are higher in after-market trading, recovering from earlier lows despite being below the 20-day moving average. No specific news was identified.

2. sept 2026, 19:46 UTC

Viking Therapeutics Inc shares are lower today, pulling back from earlier session highs amid broader market concerns over rising U.S. Treasury yields.

31. aug 2026, 19:36 UTC

Viking Therapeutics shares are higher today, despite earlier pressure, amid broader market dynamics influenced by rising interest rate expectations following comments from the Fed.

29. aug 2026, 00:01 UTC

Viking Therapeutics Inc shares rose in after-market trading, reflecting a notable increase since Friday's close, despite no specific news driving the movement.

28. aug 2026, 23:36 UTC

Viking Therapeutics Inc. shares are higher in after-market trading, gaining since Friday's close, despite fluctuations and remaining below the 20-day moving average.

27. aug 2026, 23:02 UTC

Viking Therapeutics Inc shares are higher in after-market hours following notable volatility during the session, despite no specific news to explain the movement.

26. aug 2026, 19:16 UTC

Viking Therapeutics Inc shares are higher today, though no specific news was identified to explain the price movement. The stock remains above its 20-day moving average.

25. aug 2026, 23:16 UTC

Viking Therapeutics shares are lower in after-market hours amid broader market volatility, with falling oil prices and geopolitical developments affecting investor sentiment.

24. aug 2026, 19:56 UTC

Social Media

Viking Therapeutics Inc shares are lower today, continuing a decline since Friday. Social media discussions highlight anticipation for upcoming data before Labor Day.

20. aug 2026, 20:06 UTC

Macro Event
Social Media

Viking Therapeutics Inc shares are lower, impacted by labor market data and heightened volatility, despite social media discussions suggesting potential recovery from a clinical trial.

19. aug 2026, 23:16 UTC

Viking Therapeutics Inc shares are higher in after-market hours, reflecting a gain since Wednesday's close and remaining above the 20-day moving average.

18. aug 2026, 19:16 UTC

Viking Therapeutics Inc shares are lower today, with no specific news driving the decline amid rising U.S. Treasury yields affecting the biotechnology sector.

17. aug 2026, 23:06 UTC

Viking Therapeutics Inc shares are higher in after-market trading, reflecting unusual strength. No specific company news was identified to explain the price movement.

14. aug 2026, 23:06 UTC

Viking Therapeutics Inc shares are lower in after-market hours, trading at the lower end of their one-month range and below the 20-day moving average.

13. aug 2026, 23:16 UTC

Viking Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. The stock is near its one-month low.

12. aug 2026, 23:26 UTC

Viking Therapeutics Inc is trading lower in after-market hours, reflecting notable weakness with no specific news identified to explain the decline.

7. aug 2026, 19:36 UTC

Social Media

Viking Therapeutics is rising amid broader market gains and anticipation of VK2809 trial results, with analysts noting potential for improved market position.

6. aug 2026, 23:16 UTC

Social Media

Viking Therapeutics Inc gains in after-market hours amid discussions on pharmacokinetic modeling and anticipated VKTX maintenance readout results.

5. aug 2026, 22:51 UTC

Viking Therapeutics Inc. shares are lower in after-market hours, continuing a decline from Wednesday's close amid unusual volatility and trading below the 20-day moving average.

4. aug 2026, 23:02 UTC

Social Media

Viking Therapeutics Inc shares are lower in after-market hours amid routine trading. The stock remains below its 20-day moving average.

3. aug 2026, 23:06 UTC

Viking Therapeutics shares are higher in after-market trading, reflecting positive sentiment from stronger-than-expected manufacturing PMI data indicating sector growth.

31. juuli 2026, 23:51 UTC

Viking Therapeutics Inc is higher in after-market trading, recovering from earlier session lows after four consecutive declines. The stock remains below its 20-day moving average.

30. juuli 2026, 23:56 UTC

News

Viking Therapeutics Inc. shows a modest gain in after-market hours amid a wave of biopharmaceutical mergers, including Vertex's $10 billion acquisition of Crinetics.

29. juuli 2026, 23:21 UTC

Social Media
News

Viking Therapeutics reported a Q2 loss of $1.10 per share, better than expected. The company highlighted progress in its obesity treatment pipeline.

28. juuli 2026, 23:11 UTC

News

Viking Therapeutics shares are lower in after-market hours amid ongoing challenges and a significant decline over the past two years. Analysts maintain a bullish outlook.

27. juuli 2026, 23:56 UTC

Viking Therapeutics Inc shares are lower in after-market hours, reflecting a lack of specific news and remaining below the 20-day moving average.

25. juuli 2026, 00:01 UTC

Viking Therapeutics Inc shares are lower in after-market trading, continuing a trend of four consecutive sessions finishing down. No specific news was identified.

24. juuli 2026, 21:01 UTC

Viking Therapeutics Inc. is higher in after-market trading, reversing recent losses despite no specific news driving the price movement.

Võrdlus sarnastega

Hinnamuutus

Viking Therapeutics Inc Prognoos

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

14 ratings

14

Osta

0

Hoia

0

Müü

Sentiment

By Acuity

126 / 339 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Viking Therapeutics Inc

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
help-icon Live chat